Sandra Simard

FLASH radiotherapy, defined by ultra-high dose rates (UHDR; >40 Gy/s), can reduce normal-tissue toxicity while maintaining tumor control, yet reported FLASH effects show substantial variability across experimental and preclinical studies. Dielectric materials...

Robust and quantitative treatment planning remains a critical barrier to reproducible preclinical FLASH radiotherapy (FLASH-RT) research. We developed and validated a Monte Carlo–based treatment planning interface (TPI) for electron FLASH beams, enabling accu...